C ompared with standard medical care, early use of a temporary intra-aortic balloon pump (IABP) to support heart function in patients who were critically ill with cardiogenic shock caused by heart ...

such as the intra-aortic balloon pump. Now some 40 years since its first-in-man description, the situations and strategies in which to utilize its attractive physiological properties are still ...

Specialists are debating the best approach in cardiogenic shock after a new analysis of data comparing Impella with ...

(European Heart Journal) In heart failure complicated by cardiogenic shock, early intra-aortic balloon pump (IABP) placement did not help clinical outcomes in the small randomized trial Altshock-2.

Despite substantial advancements in the management of cardiogenic shock, mortality rates remain greater than 40%. Trials have shown that increasing survival rates in cardiogenic shock is challenging.

Cardiogenic shock occurs when the heart is not able to pump enough blood to generate adequate cardiac output to maintain normal blood pressure. This frequently occurs in the setting of a large ...